• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高血压和缺血性中风患者纤维化和炎症发展的年龄相关特征。]

[Age-associated features of the development of fibrosis and inflamaging in patients with arterial hypertension and ischemic stroke.].

作者信息

Osipova O A, Gosteva E V, Belousova O N, Zhernakova N I, Klushnikov N I, Golovina N I

机构信息

Belgorod State National Research University, 85 Pobedy str., Belgorod 308015, Russian Federation, е-mail:

N.N.Burdenko Voronezh State Medical University, 10 Studencheskaya str., Voronezh 394036, Russian Federation.

出版信息

Adv Gerontol. 2021;34(6):879-884.

PMID:35152604
Abstract

The article deals with the development of fibrosis and immune inflammation in patients with arterial hypertension and acute ischemic stroke in old age. The aim of the study was to study age-associated features of the concentration of fibrosis markers (metalloproteinase-9, tissue inhibitor of matrix metalloproteinases-1, their ratio MMP-9/TIMP-1), immune inflammation (TNF-α, IL-1β, INF-γ) in patients with arterial hypertension and ischemic stroke (AI). The study included 86 patients with arterial hypertension (AH) of the 2nd degree, of which 42 were middle-aged (53±5 years) and 44 elderly (66±5 years). The control group consisted of 22 elderly patients with AH without a history of AI. The criteria for inclusion in the study are patients with hypertension who were admitted to the hospital in the acute period of the first cerebral stroke. It was found that in elderly patients with hypertension with AI, the indicators of inflamaging and fibrosis markers were significantly higher than in middle-aged people. The level of IL-1ß was 31,7% higher (p<0,01), TNF-α by 55,7% (p<0,001), INF-γ by 36,6% (p<0,01), the level of MMP-9 was 46,4% higher (p<0,01), TIMP-1 by 21,2% (p<0,01), MMP-9/TIMP-1 by 19,6% (p<0,01) in the elderly compared to middle-aged patients with hypertension and acute AI. Thus, it was found that patients with arterial hypertension and ischemic stroke have violations of the processes of inflamaging, synthesis and degradation of the extracellular matrix, especially pronounced in old age.

摘要

本文探讨老年动脉高血压患者合并急性缺血性卒中时纤维化和免疫炎症的发展情况。本研究旨在研究动脉高血压合并缺血性卒中(AI)患者中纤维化标志物(金属蛋白酶-9、基质金属蛋白酶组织抑制剂-1及其比值MMP-9/TIMP-1)、免疫炎症(TNF-α、IL-1β、INF-γ)浓度与年龄相关的特征。该研究纳入了86例二级动脉高血压(AH)患者,其中42例为中年患者(53±5岁),44例为老年患者(66±5岁)。对照组由22例无AI病史的老年AH患者组成。纳入研究的标准为首次脑卒中急性期入院的高血压患者。研究发现,老年高血压合并AI患者的炎症衰老和纤维化标志物指标显著高于中年患者。与中年高血压合并急性AI患者相比,老年患者IL-1β水平高31.7%(p<0.01),TNF-α高55.7%(p<0.001),INF-γ高36.6%(p<0.01),MMP-9水平高46.4%(p<0.01),TIMP-1高21.2%(p<0.01),MMP-9/TIMP-1高19.6%(p<0.01)。因此,研究发现动脉高血压合并缺血性卒中患者存在炎症衰老、细胞外基质合成与降解过程的异常,在老年患者中尤为明显。

相似文献

1
[Age-associated features of the development of fibrosis and inflamaging in patients with arterial hypertension and ischemic stroke.].[高血压和缺血性中风患者纤维化和炎症发展的年龄相关特征。]
Adv Gerontol. 2021;34(6):879-884.
2
[The role of inflammation in the development of post-stroke depression in elderly patients.].[炎症在老年患者中风后抑郁发生中的作用。]
Adv Gerontol. 2021;34(6):841-847.
3
Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke.血清基质金属蛋白酶-8、金属蛋白酶组织抑制剂和髓过氧化物酶与缺血性脑卒中。
Atherosclerosis. 2018 Apr;271:9-14. doi: 10.1016/j.atherosclerosis.2018.02.012. Epub 2018 Feb 8.
4
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?心房颤动中的血栓形成与基质金属蛋白酶-1及其抑制剂金属蛋白酶组织抑制因子-1有关吗?
Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27.
5
[Cognitive impairment in elderly patients with arterial hypertension who suffered an ischemic stroke depending on the presence of chronic kidney disease.].
Adv Gerontol. 2022;35(6):856-861.
6
Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.金属蛋白酶-9/金属蛋白酶组织抑制剂-1系统对原发性高血压患者大动脉僵硬度的影响。
Hypertens Res. 2007 Oct;30(10):959-63. doi: 10.1291/hypres.30.959.
7
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.血清基质金属蛋白酶-1组织抑制剂水平与恶性大脑中动脉梗死患者的死亡率相关。
BMC Neurol. 2015 Jul 11;15:111. doi: 10.1186/s12883-015-0364-7.
8
High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.血浆中金属蛋白酶组织抑制因子-1(TIMP-1)和白细胞介素-8(IL-8)水平升高是心肌梗死并发心室颤动患者的特征。
Clin Chem Lab Med. 2007;45(10):1360-5. doi: 10.1515/CCLM.2007.286.
9
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.基质金属蛋白酶-9、-10 和基质金属蛋白酶组织抑制剂-1 的血液水平作为脓毒症严重程度和死亡率的生物标志物。
Crit Care. 2009;13(5):R158. doi: 10.1186/cc8115. Epub 2009 Oct 2.
10
Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.选择的金属基质金属蛋白酶和金属蛋白酶组织抑制剂作为单侧肾积水儿童小管间质性纤维化的潜在生物标志物。
Dis Markers. 2020 Jun 29;2020:9520309. doi: 10.1155/2020/9520309. eCollection 2020.